Ceapro Announces Grant of Stock Options EDMONTON, ALBERTA -- (Marketwire) -- 01/15/13 -- Ceapro Inc. (TSX VENTURE:CZO) today announced the granting of stock options to its employees, directors, and officers for a total of 1,400,000 stock options, each with an exercise price of $0.10. Each grant vests in three equal instalments, the first of which vests immediately with the second and third instalments vesting on the first and second anniversaries of the date of grant. Each option is exercisable, once vested, for a period of ten years from the date of grant. Of note, a total of 575,000 of the stock options were granted to directors and officers. The granting of all options is subject to TSX Venture approval. About Ceapro Inc. Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of natural products for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides. To learn more about Ceapro, visit www.ceapro.com. The TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Contacts: Ceapro Inc. Branko Jankovic Chief Financial Officer (780) 917-8376 (Edmonton) firstname.lastname@example.org www.ceapro.com
Ceapro Announces Grant of Stock Options
Press spacebar to pause and continue. Press esc to stop.